Precancerous Condition
135
2
2
100
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
40 trials with published results (30%)
Research Maturity
100 completed trials (74% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
10.4%
14 terminated out of 135 trials
87.7%
+1.2% vs benchmark
13%
18 trials in Phase 3/4
40%
40 of 100 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 100 completed trials
Clinical Trials (135)
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy
Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Hepatobiliary Tumors Tissue Samples Acquisition
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
Activating Collaborative CIS Support Via Targeted Provider Mailing
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males